×
PACS Total Assets 2022-2024 | PACS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
PACS total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
PACS Total Assets 2022-2024 | PACS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
PACS total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$134.6B
CVS Health (CVS)
$78B
Elevance Health (ELV)
$62.3B
Cencora (COR)
$56.7B
DiDi Global (DIDIY)
$26.2B
Labcorp Holdings (LH)
$20.3B
Natera (NTRA)
$19.2B
BioMerieux (BMXMF)
$16.3B
EUROFINS SCIENT (ERFSF)
$13.9B
CochLear (CHEOY)
$13B
Solventum (SOLV)
$12.5B
ICON (ICLR)
$11.3B
Revvity (RVTY)
$10.7B
Viatris (VTRS)
$10.4B
Medpace Holdings (MEDP)
$8.9B
Sonic Healthcare (SKHHY)
$8.8B
Avantor (AVTR)
$8.4B
HealthEquity (HQY)
$8.4B
Charles River Laboratories (CRL)
$7.4B
Caris Life Sciences,�Inc (CAI)
$7.2B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$4.9B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.1B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.6B
Alignment Healthcare (ALHC)
$2.5B
Organon (OGN)
$2.5B
GeneDx Holdings (WGS)
$2.2B
Progyny (PGNY)
$2B